Clinical Research Directory
Browse clinical research sites, groups, and studies.
Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use
Sponsor: Douglas Mental Health University Institute
Summary
Cognitive impairment is well established in people with psychosis and is associated with cannabis use. The current study will investigate the neurobiological basis of cognitive change associated with 28-days of cannabis abstinence in people with psychosis and non-psychiatric controls with cannabis use. Participants will be randomized to a cannabis abstinent group or a non-abstinent control group and will undergo magnetic resonance imaging at baseline and following 28-days of abstinence. This study will help characterize the neuropathophysiological processes underlying cognitive dysfunction associated with cannabis use and its recovery which may guide the development of novel interventions for problematic cannabis use.
Official title: Investigating the Neural Correlates of Cognitive Function Associated With Cannabis Abstinence in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use
Key Details
Gender
All
Age Range
16 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
134
Start Date
2022-04-21
Completion Date
2027-05
Last Updated
2024-05-03
Healthy Volunteers
Yes
Conditions
Interventions
Contingency management
Contingency management will be used to encourage abstinence
Locations (1)
Douglas Mental Health University Institute
Montreal, Quebec, Canada